Remeron: Restore Restful Sleep and Mood Balance
| Product dosage: 30mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $3.15 | $94.38 (0%) | 🛒 Add to cart |
| 60 | $2.49 | $188.77 $149.61 (21%) | 🛒 Add to cart |
| 90 | $2.29 | $283.15 $205.84 (27%) | 🛒 Add to cart |
| 120 | $2.18 | $377.53 $261.06 (31%) | 🛒 Add to cart |
| 180 | $2.06 | $566.30 $371.51 (34%) | 🛒 Add to cart |
| 270 | $2.00
Best per pill | $849.45 $539.19 (37%) | 🛒 Add to cart |
Synonyms
| |||
Remeron (mirtazapine) is a prescription antidepressant medication belonging to the class of noradrenergic and specific serotonergic antidepressants (NaSSA). It is primarily indicated for the treatment of major depressive disorder (MDD) in adults. Unlike many conventional antidepressants, Remeron’s unique mechanism not only helps alleviate symptoms of depression but also significantly improves sleep quality early in treatment, often within the first week of use. Its sedative properties, coupled with a favorable side effect profile regarding sexual dysfunction, make it a valuable option for patients struggling with both depressive symptoms and sleep disturbances.
Features
- Active ingredient: Mirtazapine
- Available in 7.5 mg, 15 mg, 30 mg, and 45 mg orally disintegrating tablets (ODT) and standard tablets
- Belongs to the NaSSA class (noradrenergic and specific serotonergic antidepressant)
- Enhances central noradrenergic and serotonergic activity via antagonism of central alpha-2 adrenergic autoreceptors and heteroreceptors
- Also acts as an antagonist at 5-HT2 and 5-HT3 receptors, and a potent antagonist at H1 histaminergic receptors
- Orally disintegrating formulation allows administration without water
Benefits
- Rapid improvement in sleep continuity and quality, often within the first week of treatment
- Effective relief from core symptoms of depression, including low mood, anhedonia, and psychomotor retardation
- Lower incidence of sexual side effects compared to SSRIs and SNRIs
- May stimulate appetite and promote weight gain, beneficial in depressed patients with weight loss or poor nutritional status
- Once-daily dosing regimen enhances adherence and simplifies treatment
- Reduced nausea and gastrointestinal distress compared to many serotonergic antidepressants
Common use
Remeron is FDA-approved for the treatment of major depressive disorder (MDD) in adults. Its use is supported by numerous clinical trials demonstrating efficacy in reducing depressive symptomatology as measured by standardized scales such as the Hamilton Depression Rating Scale (HAM-D). Clinicians may also prescribe it off-label for conditions such as generalized anxiety disorder (GAD), panic disorder, post-traumatic stress disorder (PTSD), and as an adjunct for insomnia, particularly when comorbid with depression. Its sedating effects are most pronounced at lower doses, making it especially useful for patients with prominent sleep initiation or maintenance problems.
Dosage and direction
The recommended starting dose for Remeron is 15 mg daily, administered orally, preferably in a single dose at bedtime. Dosage may be increased gradually, depending on clinical response and tolerability, to a maximum of 45 mg per day. Dosage adjustments should be made at intervals of no less than 1–2 weeks. The orally disintegrating tablet should be placed on the tongue and allowed to disintegrate; swallowing with water is not necessary. Administration with food may minimize potential dizziness. Elderly patients and those with hepatic or renal impairment may require lower initial doses and more cautious titration.
Precautions
Patients should be monitored for clinical worsening, suicidality, or unusual changes in behavior, especially during the initial few months of therapy or following dosage changes. Remeron may impair judgment, thinking, or motor skills; patients should avoid driving or operating machinery until they know how the medication affects them. Caution is advised in patients with a history of seizures, hepatic impairment, renal impairment, cardiovascular disease, or angle-closure glaucoma. Use in elderly patients may increase the risk of hyponatremia or falls. Alcohol should be avoided due to additive CNS depression.
Contraindications
Remeron is contraindicated in patients with known hypersensitivity to mirtazapine or any component of the formulation. Concomitant use with monoamine oxidase inhibitors (MAOIs) or within 14 days of discontinuing MAOI therapy is contraindicated due to the risk of serotonin syndrome. It should not be used in patients with severe hepatic impairment. Use is also contraindicated in conditions where sedation poses a significant risk.
Possible side effects
Common side effects (≥1% incidence) include somnolence, increased appetite, weight gain, dry mouth, constipation, dizziness, and asthenia. Less frequently, patients may experience abnormal dreams, confusion, tremor, peripheral edema, or elevated transaminases. Although uncommon, serious side effects may include agranulocytosis, seizures, activation of mania/hypomania, serotonin syndrome, orthostatic hypotension, and hyponatremia. Any signs of infection (e.g., fever, sore throat) should be promptly evaluated due to the rare risk of agranulocytosis.
Drug interaction
Remeron is metabolized primarily by CYP450 enzymes (CYP1A2, CYP2D6, CYP3A4). Concomitant use with strong CYP450 inhibitors (e.g., fluoxetine, ketoconazole) may increase mirtazapine levels. Use with MAOIs is contraindicated. Caution is advised with other CNS depressants (e.g., benzodiazepines, opioids, alcohol) due to additive sedation. Remeron may potentiate the effects of antihypertensive agents. It may interact with serotonergic drugs (e.g., tramadol, linezolid, triptans) increasing the risk of serotonin syndrome.
Missed dose
If a dose is missed, it should be taken as soon as remembered, unless it is almost time for the next scheduled dose. In that case, the missed dose should be skipped, and the regular dosing schedule resumed. Doubling the dose to make up for a missed one is not recommended.
Overdose
Symptoms of overdose may include disorientation, drowsiness, impaired memory, tachycardia, and hypertension. Severe overdose may lead to prolonged sedation, respiratory depression, or cardiovascular instability. There is no specific antidote; management involves supportive care and symptomatic treatment. Gastric lavage may be considered if presented early. ECG monitoring is advised due to potential QT prolongation at high doses.
Storage
Store at room temperature (20–25°C or 68–77°F), away from light and moisture. Keep in the original container, tightly closed. Do not remove desiccant from the bottle. Keep out of reach of children and pets.
Disclaimer
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or medication. Do not disregard professional medical advice or delay in seeking it because of something you have read here.
Reviews
Clinical studies and patient reports frequently highlight Remeron’s efficacy in improving sleep quality and reducing depressive symptoms, especially in cases where other antidepressants have failed or caused intolerable side effects. Many users note significant improvement in sleep within days, though weight gain is a commonly reported drawback. Reviews often emphasize its value in treating depression with comorbid anxiety or insomnia, though individual responses can vary. Always consult a healthcare professional for personalized medical advice.